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Background: No tool exists to measure self-efficacy for overcoming lymphedema-related exercise barriers in individuals
with cancer-related lymphedema. However, an existing scale measures confidence to overcome general exercise barriers
in cancer survivors. Therefore, the purpose of this study was to develop, validate and assess the reliability of a subscale, to
be used in conjunction with the general barriers scale, for determining exercise barriers self-efficacy in individuals facing
lymphedema-related exercise barriers.
Methods: A lymphedema-specific exercise barriers self-efficacy subscale was developed and validated using a cohort of
106 cancer survivors with cancer-related lymphedema, from Brisbane, Australia. An initial ten-item lymphedema-specific
barrier subscale was developed and tested, with participant feedback and principal components analysis results used to
guide development of the final version. Validity and test-retest reliability analyses were conducted on the final subscale.
Results: The final lymphedema-specific subscale contained five items. Principal components analysis revealed these items
loaded highly (>0.75) on a separate factor when tested with a well-established nine-item general barriers scale. The final
five-item subscale demonstrated good construct and criterion validity, high internal consistency (Cronbach’s alpha = 0.93)
and test-retest reliability (ICC = 0.67, p < 0.01).
Conclusions: A valid and reliable lymphedema-specific subscale has been developed to assess exercise barriers
self-efficacy in individuals with cancer-related lymphedema. This scale can be used in conjunction with an existing
general exercise barriers scale to enhance exercise adherence in this understudied patient group.
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Cancer-related lymphedema is reported as one of the most
feared and problematic cancer survivorship concerns [1,2].
A potentially chronic condition, it typically presents as
swelling in the limbs, trunk, head, neck or groin, de-
pending on the cancer type. Lymphedema following
breast cancer occurs in approximately 20% of women
within 18 months of treatment [3], with additional new
cases presenting beyond this period [2,4]. While incidence
rates for lymphedema in other cancers are limited, a meta-
analysis found that, overall, approximately 15% of those
with melanoma, sarcoma, genitourinary, gynecological or* Correspondence: jena.buchan@qut.edu.au
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unless otherwise stated.head/neck cancer subsequently developed cancer-related
lymphedema [5].
Participating in regular exercise during and following
cancer treatment is considered effective for counteract-
ing treatment-related morbidity, improving function and
quality of life, and possibly improving cancer-specific
and overall survival [6-9]. Exercise may also help manage
lymphedema, but research is predominately limited to
breast cancer-related lymphedema [10]. However, des-
pite growing evidence on the importance of engaging in
exercise post-cancer, findings from breast cancer studies
suggest that approximately 55% do not engage in nation-
ally recommended levels of physical activity [11,12], and
nearly 60% report declines in physical activity following
their cancer diagnosis [13]. Further, the proportion of
women engaging in sufficient levels of physical activity is. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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participation in physical activity has been associated with
less exacerbation of lymphedema-related symptoms in
breast cancer survivors [16]. Understanding exercise bar-
riers and self-efficacy for individuals with cancer-related
lymphedema will aid international physical activity behav-
iour change strategies post-cancer diagnosis. Moreover, this
information can be used to enhance adherence in the exer-
cise and cancer efficacy trials needed in those cancer types
for which less is known about the effects of exercise on
lymphedema (e.g., gynaecologic, head and neck).
Exercise barriers self-efficacy is a term used to describe
the confidence to overcome barriers and partake in exer-
cise [17], with higher physical activity levels observed in
individuals reporting greater self-efficacy to overcome
such barriers [18-20]. Common general exercise barriers
identified by healthy and clinical populations include
time, motivation, social support and weather [17,21-24].
These common barriers may be even greater for cancer
survivors due to potentially increased time pressures cre-
ated by cancer-related medical appointments and treat-
ment requirements [25]. However, cancer survivors also
encounter unique barriers to exercise that arise as a conse-
quence of their cancer and its treatment. These may in-
clude the presence of treatment-related side effects such as
nausea or fatigue, reduced functional capacity or uncer-
tainty about what exercise is safe [15,24,26]. Lymphedema-
related barriers, such as the presence of swelling, pain and
altered sensation in the affected body area, as well as feel-
ings of fear and uncertainty about making the lymphedema
worse, may also exist [15,27,28]. While a scale exists
measuring the impact of general barriers on exercise
barriers self-efficacy, there is no current tool including
lymphedema-related exercise barriers. Therefore, the
purpose of this study was to develop, validate and as-
sess the reliability of a lymphedema-specific subscale
for measuring exercise barriers self-efficacy in individ-
uals with cancer-related lymphedema.
Methods
Ethical approval for this study was obtained from the
Queensland University of Technology Research Ethics Unit,
Brisbane, Australia (Approval # 1100001471). This research
has been performed in accordance with the ethical stan-
dards laid down in the 1964 Declaration of Helsinki.
Scale development
A convenience sample of men and women with cancer-
related lymphedema was recruited through a local private
physiotherapy practice specializing in treatment of lymph-
edema. Eligibility criteria included a diagnosis of secondary
lymphedema due to cancer treatment. Eligible clinic pa-
tients were mailed a study information letter and question-
naire by clinic staff to ensure researcher blinding andpatient confidentiality. Invited patients were informed that
participation was voluntary and could not be tracked, and
consent was implied by return of the questionnaire in the
provided reply-paid envelope. Participants were also given
the opportunity to provide details if they wished to be
contacted about providing scale feedback and other future
research. A follow-up letter and additional copy of the
questionnaire was sent out approximately one month after
the initial mailing to maximise response rate.
Initially, ten lymphedema-specific barriers were included.
These barriers were identified following review of qualita-
tive and quantitative exercise and lymphedema research
[10,27,29-33], and consultation with experts (i.e., allied
health professionals and researchers experienced in ex-
ercise and lymphedema; backgrounds in exercise sci-
ence, psychology, lymphedema management, cancer
survivorship and physiotherapy). The barrier identifica-
tion process highlighted that individuals with cancer-
related lymphedema face condition-related barriers, as well
as general exercise barriers. Therefore, the lymphedema-
specific items were designed to be used as a subscale for a
previously validated nine-item exercise barriers self-efficacy
scale assessing general barriers (internal consistency,
Cronbach’s alpha = 0.95; test-retest reliability, r = 0.89,
p < 0.001) [17], which was also included in the survey.
The format of the ten-item lymphedema-specific subscale
followed the same format as this pre-existing general self-
efficacy validated scale [17]. Therefore, participants were
asked to indicate their confidence to overcome barriers
(nine general and ten lymphedema-specific) on a scale
ranging from 0% (not at all confident) to 100% (ex-
tremely confident), with 10% intervals. As is standard
procedure for the general self-efficacy scale, responses
were then categorised as 0-20% = not at all confident;
20-40% = slightly confident; 40-60% =moderately confident;
60-80% = very confident; 80-100% = extremely confident.
Additionally, a follow-up survey mail-out was done to par-
ticipants that provided contact details expressing interest in
future research participation, enabling participants to pro-
vide feedback on scale structure and whether there were
any relevant barriers missed.
Scale refinement
Construct validity of the ten-item lymphedema-related sub-
scale was assessed by measuring its correlation with the pre-
existing general barriers scale [17]. A principal components
analysis was done to determine if all ten items loaded on a
single factor. Data from validity testing and factor analysis
were then used, in conjunction with participant feedback, to
help determine which items to include in the final subscale.
Testing of final scale
Once revised, validity and reliability testing was com-
pleted on the revised lymphedema-specific subscale
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unilateral breast cancer-related lymphedema. These partici-
pants were women who had partaken in previous research
studies conducted by study investigators, and who had noti-
fied us that they were interested in participating in future
research. Participants completed the final scale on two oc-
casions, with a two-week interval before repeat assessment.
To conduct validity testing, three additional self-report
questionnaires were completed, on quality of life, upper-
body function and physical activity levels. Quality of life
was measured using Functional Assessment of Cancer
Therapy-Breast + 4 (FACT-B + 4). This scale, designed spe-
cifically for breast cancer patients, has been shown to have
sufficient test-retest reliability (r = 0.97) and good internal
consistency (alpha coefficient = 0.62 to 0.88) [34]. Upper-
body function was assessed using the Disabilities of the
Arm, Shoulder and Hand (DASH) questionnaire, a vali-
dated tool that measures the impact of upper-limb limita-
tions on daily life (alpha = 0.96) [35]. The Active Australia
survey was used to assess weekly physical activity participa-
tion. Total number of sessions and time spent engaged in
activity is calculated and reported as “sedentary” (physical
activity = 0 minutes), “insufficient” (physical activity <
150 min OR physical activity ≥ 150 min and number of
sessions < 5) or “sufficient” (physical activity ≥ 150 min
AND number of sessions ≥ 5). The Active Australia
survey has demonstrated good test-retest reliability and
validity (intra-class correlations = 0.71-0.86; Spearman’s
Rho = 0.54-0.77; Kappa statistics = 0.52) [36,37].
Statistical analysis
Frequencies were run for all items on the original and
final version of the lymphedema-specific subscale, to
check for any invalid values and potential outliers. As is
standard procedure for the general exercise barriers self-
efficacy scale [38], if participants missed individual items,
and as long as responses for less than 33% of items were
missing, the mean of remaining items was imputed to
allow calculation of the total scale score. When participants
missed more than 33% of items, their data were excluded
from analysis.
Principal components analysis with direct oblimin ro-
tation was completed for final subscale analyses. To
validate the subscale, we correlated scores from the
lymphedema-specific subscale with the ten-item general
barriers scale. Correlations were also calculated be-
tween the lymphedema-specific subscale and quality of
life (FACT-B + 4;) and upper-body function (DASH)
(construct [discriminant] validity) scores, as well as phys-
ical activity levels (criterion validity; one-way ANOVA).
We expected low correlations between the scale and qual-
ity of life and upper-body function, given the differences
in these constructs. However, higher self-efficacy levels
were expected in participants reporting higher physicalactivity levels. The internal consistency (i.e., Cronbach’s
coefficient alpha) and test-retest reliability statistics (i.e.,
intraclass correlation coefficients [ICC] and paired-sample
t-tests) were also calculated. Intraclass correlation coeffi-
cients were used to determine how well repeated mea-
surements resembled one another (i.e., how consistent
participants were in responding), and paired-sample
t-tests were used to examine if changes in response were
statistically significant from initial to repeat assessment for
any item.
Results
Participant characteristics
Responses from 68 (64%) of the original sample were
received, with their data being used for psychometric
assessment of the original lymphedema-specific subscale
(ten items), while 38 participants (93% of the second sam-
ple) provided data for psychometric testing (five items)
of the revised subscale. The data and feedback collec-
tion processes are outlined in Figure 1.
Table 1 presents an overview of participant demographic
and medical characteristics of the two convenience sam-
ples. Briefly, sample one and two were similar in age (mean
[95%CI]: 59.6 [57.1,62.1] and 56.3 [53.1,59.5] years, respect-
ively) and the majority were employed (64.7% and 57.9%,
respectively) and lived with a partner (married, de facto or
serious partner; 77.9% and 63.2%, respectively). The major-
ity of respondents reported participating in some weekly
physical activity (91.2% and 86.8%, respectively). Key differ-
ences between samples were that all individuals from the
second sample had lymphedema following breast cancer,
compared with only 66% of those in the first sample.
Further, compared with sample two, more respondents
in sample one had lymphedema for longer than five
years (sample one: 25%; sample two: 13%).
Original subscale
Results from the principal components analysis on the
original ten-item lymphedema-specific subscale (Table 2)
suggested items loaded on two factors, which accounted
for 73.5% of the total variance. Eight items loaded well
on the first factor (0.67 to 0.88), and two items (“when I
am lifting/moving heavy objects a few times” and “when I
am lifting/moving light objects repetitively”) loaded on the
second factor (0.90 and 0.95). Scores on the general and
lymphedema-specific scales were strongly correlated, indi-
cating good construct validity (Pearson’s r = 0.72, p < 0.01).
Twenty-one respondents (20%) from sample one pro-
vided feedback on the subscale and suggested inclusion of
items that dealt with lack of time and/or motivation, work
and family commitments, exacerbation of lymphedema
symptoms, embarrassment, pain, lack of confidence, and
limited advice following treatment. Since most of these
suggestions are already covered by the general self-efficacy
Table 1 Descriptive characteristics of participants
Variable Original scale sample Final scale sample
(N = 68) (N = 38)
n (%) n (%)
Age (year)
Age, mean (95% CI) 59.6 (57.1,62.1) 56.3 (53.1,59.5)
Gender
Male 5 (7.4) 0 (0)
Female 63 (92.6) 38 (100)
Marital Status
Married/de facto 53 (77.9) 24 (63.2)
Single/widowed/divorced 15 (22.1) 14 (36.8)
Employment status
Paid employment 44 (64.7) 22 (57.9)
Unemployed/retired/unpaid work 24 (35.3) 16 (42.1)
Total physical activitya
Sedentary 6 (8.8) 5 (13.2)
Insufficient 21 (30.9) 13 (34.2)
Sufficient 41 (60.3) 20 (52.6)
Cancer
Breast 45 (66.2) 38 (100)
Gynaecological 14 (20.6) 0 (0)
Other (skin, bowel, prostate) 9 (13.2) 0 (0)
Duration with lymphedema
<2 years 26 (38.2) 16 (42.1)
2-5 years 25 (36.8) 17 (44.7)
>5 years 17 (25.0) 5 (13.2)
CI = confidence intervals; min =minutes.
asedentary = no weekly physical activity; insufficient = < 150 min OR ≥ 150 min and < 5 sessions per week; sufficient = ≥ 150 min and ≥ 5 sessions per week.
68 respondents completed the
survey (64%)
21 provided feedback (49% of those who
received feedback survey; 20% of those
who received the inial survey)
Mailing of original subscale (n=107)
43 respondents provided contact details
and were mailed feedback survey (63%)
Final subscale and test-retest scale sent
to 2nd convenience sample (n=41)
32 individuals provided
test-retest data (78%)
38 respondents completed the
survey (93%)
Figure 1 Participant response flow.
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Table 2 Original lymphedema-specific exercise barriers self-efficacy subscale
Using the scale from 0-100%, indicate how confident you are that you could exercise in each of the following situations. Even if you are
not currently exercising, please read and respond to each question by circling one number for each situation.
Not at all
confident
Slightly
confident
Moderately
confident
Very
confident
Extremely
confident
When I am worried about my appearance. 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
When my affected body segment feels heavy. 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
When my affected body segment is painful. 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
When my affected body segment is numb or tingling. 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
When I fear making my lymphoedema worse. 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
When I am unsure what exercise advice to follow. 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
When I am not certain if I am doing an exercise correctly. 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
When I am lifting/moving heavy objects a few times. 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
When I am lifting/moving light objects repetitively. 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Buchan et al. Health and Quality of Life Outcomes  (2015) 13:37 Page 5 of 8scale, it highlighted the necessity for concurrent assessment
of general and lymphedema-specific exercise barriers
self-efficacy. Respondents also suggested clarifying the
question on embarrassment about appearance (whether
this was lymphedema-related or general, due to for ex-
ample obesity or being unfit) and suggested defining
the term ‘exercise’ , which is used in the questionnaire
instructions. Of note, 4 of the 21 respondents providing
feedback had a cancer type other than breast (i.e.,
gynecological, bowel) with suggestions for additional
barriers being similar for breast and non-breast cancer
survivors.
Final subscale
By considering results from the factor analysis and partici-
pant feedback, the original ten items in the lymphedema-
specific subscale were reduced to a five-item subscale
(Table 3) to be used in conjunction with the nine-item
general exercise barriers self-efficacy scale. Three of the
five items reflect original, unchanged items: “when I fear
making my lymphedema worse”, “when I am not certain I
am doing an exercise correctly”, and “when I am unsure
what exercise advice to follow”. In line with participantTable 3 Final lymphedema-specific exercise barriers self-effica
Using the scale from 0-100%, indicate how confident you are that you
planned physical activity undertaken for health benefits, e.g. lifting we
please read and respond to each question by circling one number for e
Not at all
confident
When I am worried about my appearance (e.g. due to swelling
and/or compression garment).
0% 10%
When I am experiencing lymphoedema-related symptoms
(e.g. pain, heaviness, numbness/ tingling, swelling).
0% 10%
When I fear making my lymphoedema worse. 0% 10%
When I am unsure what exercise advice to follow. 0% 10%
When I am not certain if I am doing an exercise correctly. 0% 10%feedback, the appearance barrier question was reworded
to clarify that it was related to worry regarding swelling
and compression garment use (“when I am worried about
my appearance [e.g., due to swelling and/or compression
garment]”) and the four original items about side-effects
as a barrier (heaviness, swelling, numbness/tingling and
pain) were collapsed into a single item. The two items
loading on a separate factor in the original subscale princi-
pal components analysis were removed, also guided by
participant feedback suggesting these items were only
relevant in certain situations (i.e., during resistance-based
exercise).
Scale structure: Results of the principal components
analysis applied to data collected from the second sam-
ple showed that items loaded on two significant factors
(that is, the nine-item general exercise barriers self effi-
cacy items loaded on factor one and the five items from
the lymphedema-specific subscale loaded on factor two),
and together accounted for 76.6% of the total variance.
Factor loadings for the nine items of the general self-
efficacy scale [30] and the five-item lymphedema-specific
subscale ranged from 0.60 to 0.95 and 0.64 to 0.97,
respectively.cy subscale
could exercise in each of the following situations (‘exercise’ is
ights, planned walks, swimming). Even if not currently exercising,
ach situation.
Slightly
confident
Moderately
confident
Very
confident
Extremely
confident
20% 30% 40% 50% 60% 70% 80% 90% 100%
20% 30% 40% 50% 60% 70% 80% 90% 100%
20% 30% 40% 50% 60% 70% 80% 90% 100%
20% 30% 40% 50% 60% 70% 80% 90% 100%
20% 30% 40% 50% 60% 70% 80% 90% 100%
Table 4 Paired-sample t-test values for test-retest reliability of final five-item lymphedema-specific subscale
Scale item Test-retest mean difference (95% CI) t-score p-value
Total scale 0.79 (−5.28, 6.87) −0.266 0.792
When I am worried about my appearance −3.75 (−10.53, 3.03) 1.129 0.268
When I am experiencing lymphedema-related symptoms 3.75 (−5.49, 12.99) −0.828 0.414
When I fear making my lymphedema worse 2.50 (−6.84, 11.84) −0.546 0.589
When I am unsure what exercise advise to follow 2.09 (−5.15, 9.33) −0.589 0.560
When I am not certain if I am doing an exercise correctly −0.63 (−8.50, 7.25) 0.162 0.872
CI = confidence intervals.
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correlated with the ten-item general barriers scale, indicat-
ing good construct validity (Pearson’s r = 0.61, p < 0.01).
The lymphedema-specific scale was poorly associated with
quality of life (FACT-B + 4) and upper-body function
(DASH) (Pearson’s r = 0.31 and Pearson’s r = −0.34, re-
spectively). Criterion validity testing showed individuals
classified as both insufficiently active (>0 min but <
150 min OR ≥ 150 min and < 5 sessions weekly) and suf-
ficiently active (≥150 min and ≥ 5 sessions weekly) had
higher self-efficacy scores (mean [SD]: 62.1 [15.7] and 56.7
[23.9], respectively) than individuals performing no phys-
ical activity (42.4 [30.4]), though this difference was not
supported statistically (p = 0.24).
Reliability: Cronbach’s alpha score of the final sub-
scale was high (alpha = 0.93), indicating strong internal
consistency. Participants answered the scale consistently
at the test and re-test time-points, with their overall score
of the first and second completion correlating highly
(ICC = 0.67, p < 0.001). Test-retest correlations of indi-
vidual items ranged from 0.44 to 0.65 (p < 0.01 for all).
Paired-sample t-test showed no statistically significant
change from initial to repeat assessment for any item
(Table 4).
Conclusions
This study has led to the development of a valid and reli-
able exercise barriers self efficacy scale to assess confidence
in ability to exercise when faced with barriers experienced
by individuals with cancer-related lymphedema. This scale
combines ten general exercise barriers, a pre-existing scale
developed by Rogers and colleagues [17], with five
lymphedema-specific barriers, a subscale developed in
this study. The subscale correlated highly with the general
self-efficacy scale, but formed a distinct separate factor,
indicating the importance of lymphedema-specific barriers
to exercise.
This study addresses a key gap in the evidence, as previ-
ously only scales that assess general exercise barriers in
breast cancer survivors [17,39] or ‘healthy’ populations
[40] were available. Initial validity testing conducted as
part of this study is promising. As has been demonstratedin general [18] and cancer [41] populations with the gen-
eral exercise barriers self-efficacy scale, participants who
had lower self-efficacy engage in less activity compared
with those who report higher self-efficacy. Importantly,
the scale does not overlap with the measurement of
other constructs, such as quality of life and upper-body
function.
Reliability testing yielded an alpha coefficient of 0.93 for
the final lymphedema-specific subscale. This is a high value
and similar to those found for other exercise barriers self-
efficacy scales [17,39]. It may indicate that the five items
within the lymphedema-specific scale are too similar and
further items are needed that cover other lymphedema-
related barriers not yet described, or may be a reflection of
the homogeneity of samples in the previous, as well as our,
studies. Nevertheless, additional barriers were not identi-
fied when feedback was obtained from the sample com-
pleting the original ten-item subscale. Test-retest reliability
for the subscale was good (ICC = 0.67), with values for in-
dividual items ranging between 0.44 and 0.65. The overall
mean differences for each item from test to retest ranged
from 0.6 to 3.8 points and all responses remained within
the same category; for example participants were still
‘moderately confident’ on the initial and re-test scale for
any given item. These findings are consistent with those
found by Rogers and colleagues [17], in their validity and
reliability testing of the original nine-item general barriers
scale. In practice, these findings suggest that the total scale
score is robust, but that it is not ideal to focus on results
from any one specific item within the scale.
It should be noted that scale construction and validity
and reliability testing was undertaken using two, rela-
tively small (N = 68 and N = 38), convenient and likely
homogenous samples (66% and 100% of sample one
and two respectively were women with breast cancer-
related lymphedema and >75% of the samples had lymph-
edema for less than five years). Additionally, no data were
available on non-respondents, so it cannot be determined
how representative this sample was of the general lymph-
edema population. Both sample size and homogeneity
have important implications for results of the principal
components analysis, with further testing warranted in a
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load on a single lymphedema barrier self-efficacy factor.
Nonetheless, the initial subscale development process col-
lected barriers reported by survivors with breast and non-
breast cancer-related lymphedema. Specifically, we were
able to make use of qualitative data collected from focus
groups and telephone interviews exploring how individuals
with cancer-related lymphedema (16 in focus groups of
2–4 participants, 13 completing telephone interviews) con-
struct their experience in daily life [33]. Participants in this
qualitative work included men and women with lymph-
edema following treatment for breast, gynecological or
‘other’ cancers. As part of this qualitative work, participants
were questioned about potential barriers of participation in
physical activity with issues raised incorporated into the
original subscale. This information was further supple-
mented by consultation of specialists in the field (dealing
with patients with upper- and lower-limb lymphedema), an
extensive literature search and incorporation of written
participant feedback following completion of our original
subscale. Our results showed, in looking at characteristics
of participants providing feedback, there were no key
differences in feedback received from people with breast
versus other cancer-related lymphedema. As such, it is
feasible that the lymphedema-specific barriers included
are relevant to, and representative of the barriers faced
by, individuals with lymphedema following cancer other
than breast.
Using the new lymphedema-specific subscale along
with the existing general barriers self-efficacy scale by
Rogers and colleagues’ [17] will allow healthcare pro-
fessionals and patients to identify low self-efficacy
for overcoming exercise barriers when cancer-related
lymphedema is a concern. In turn, this should assist
patients and their support team in identifying ways to
overcome barriers and improve exercise uptake and
adherence. The addition of the lymphedema-specific
scale in future exercise interventions involving people
with cancer-related lymphedema may also be useful to
help guide individual program design. Baseline mea-
surements of overall self-efficacy levels at the start of
an exercise intervention can be used to identify partici-
pants that may be at risk of poorer adherence [12,19]
and to guide and individualize the level of support dur-
ing exercise interventions or programing. Alternatively,
researchers could assess whether baseline self-efficacy
levels influence the effect of exercise interventions or
whether participation in an exercise intervention has
the potential to increase self-efficacy levels. In sum-
mary, this work extends the research in exercise bar-
riers self-efficacy in the general cancer population into
the understudied area of cancer-related lymphedema.
In doing so, future research in this area could assist
those with cancer-related lymphedema to become moreconfident in overcoming barriers and engaging in exercise,
ultimately improving their physical and psychosocial
well-being.
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